Palakurthi, Srinath
Texas A&M University-Kingsville,
United States
2025 Rank: 257168
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2063 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 257168 | 279656 |
| Total Cites | 280 | 295 |
| H-index | 8 | 8 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 14 | 14 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 219 | 229 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 268 | 279 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.06 |
| Self-Citation Percentage |
5.08%
|
|
Palakurthi, Srinath
Texas A&M University,
United States
2024 Rank: 315836
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2603 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 315836 | 332363 |
| Total Cites | 229 | 243 |
| H-index | 8 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 9 | 9 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 191 | 200 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 218 | 232 |
| Ratio of Total Citations to Distinct Citing Papers | 1.05 | 1.05 |
| Self-Citation Percentage |
5.76%
|
|
Palakurthi, Srinath
Texas A&M University,
United States
2023 Rank: 278651
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2285 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 278651 | 297068 |
| Total Cites | 228 | 242 |
| H-index | 7 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 10 | 10 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 206 | 216 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 222 | 233 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.04 |
| Self-Citation Percentage |
5.79%
|
|
Palakurthi, Srinath
Texas A&M University,
United States
2022 Rank: 228318
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1828 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 228318 | 265277 |
| Total Cites | 203 | 207 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 11 | 11 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 182 | 183 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 200 | 202 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.02 |
| Self-Citation Percentage |
1.93%
|
|
Palakurthi, Srinath
Texas A&M University,
United States
2021 Rank: 249266
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1988 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 249266 | 274095 |
| Total Cites | 288 | 303 |
| H-index | 8 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 20 | 20 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 272 | 277 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 283 | 296 |
| Ratio of Total Citations to Distinct Citing Papers | 1.02 | 1.02 |
| Self-Citation Percentage |
4.95%
|
|
Palakurthi, Srinath
Texas A and M Health Science Center,
United States
2020 Rank: 204241
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1439 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 204241 | 225763 |
| Total Cites | 232 | 238 |
| H-index | 7 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 21 | 21 |
| Number of Single+First+Last Authored Papers | 25 | 25 |
| Total Cites to Single+First+Last Authored Papers | 222 | 226 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 226 | 232 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.03 |
| Self-Citation Percentage |
2.52%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.